Hot Life Science Investor Mandate 2: Chinese PE Firm Looking Globally for Devices

26 Jun

A global alternative asset manager based in China focuses on investments in the healthcare sector, providing equity and/or mezzanine capital to early and growth-stage companies. The firm has raised four funds to date and is making new investments from its fourth 2014 vintage fund. Depending on the stage of the company, the firm can invest from several hundred thousand to tens of millions. The firm is geographically agonistic and looks to invest in companies based in the US, Europe, Israel, and Asia. The firm is actively seeking new investment opportunities.       

In the Life Sciences the firm is currently seeking to invest in medical devices. The firm primarily invests in novel and disruptive technologies. The firm is opportunistic in terms of the class/type and development stage of the device. Hence, the firm will consider devices at all stages: prototype, in clinic, to commercial stage. The firm is currently looking for opportunities in the hypertension, oncology, and diabetes market. Currently the firm is only looking for privately held companies. 

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: